Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.
about
Associations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese populationAssociation between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placentaLocalization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activityHigh doses of ursodeoxycholic acid up-regulate the expression of placental breast cancer resistance protein in patients affected by intrahepatic cholestasis of pregnancyMaternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrierRole of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins.Regulation of drug transporter expression and function in the placenta.Synchronized activity of organic cation transporter 3 (Oct3/Slc22a3) and multidrug and toxin extrusion 1 (Mate1/Slc47a1) transporter in transplacental passage of MPP+ in rat.The Role of PXR Genotype and Transporter Expression in the Placental Transport of Lopinavir in Mice.Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine.Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta
P2860
Q28395070-38BD86E2-46A7-42F1-8C0B-1E2AC9047979Q31133417-761A2134-B7DF-485D-8235-6BB1D0A21AC0Q32174706-E506AD40-7C7A-45CE-B544-4648F9C9ACFBQ34745175-01DCEDFE-E451-41A6-B96E-C5FAFE05259CQ36306228-34CE1D80-3E66-4F52-8440-3D10F43EFAF7Q36476735-2C0EC77D-E79C-437E-98E2-EBF834AFDDCFQ37203806-2DB5CB0F-3ACA-4C04-BD61-D9FA08F031F9Q38044958-11D45206-4172-4155-9B9D-1F86E1BAE26EQ38051400-33B9727D-41BC-433C-939D-B75D951A4362Q38222511-004301EE-5FFF-4EAF-AE2B-088565148631Q38323562-EECCA56C-F467-470D-B37A-A08192B4B24CQ39356896-EBA0CE92-E5C2-47B3-B48C-40FD9E4C22E6Q47397797-E6465E0D-60F6-4E80-9BF4-35F00E1981D3Q53816970-5582402E-D9CF-4C01-80D2-4202BAEA4256Q53818047-B83B91F1-1739-4604-A224-EEF62776F50DQ58746190-6CDECCE7-6076-491C-84FE-77DA4AEED8D6
P2860
Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fetoprotective activity of bre ...... function throughout pregnancy.
@en
Fetoprotective activity of bre ...... function throughout pregnancy.
@nl
type
label
Fetoprotective activity of bre ...... function throughout pregnancy.
@en
Fetoprotective activity of bre ...... function throughout pregnancy.
@nl
prefLabel
Fetoprotective activity of bre ...... function throughout pregnancy.
@en
Fetoprotective activity of bre ...... function throughout pregnancy.
@nl
P2093
P2860
P1476
Fetoprotective activity of bre ...... function throughout pregnancy.
@en
P2093
Frantisek Staud
Lenka Hahnova-Cygalova
Martina Ceckova
P2860
P356
10.3109/03602532.2010.512293
P407
P577
2010-09-20T00:00:00Z